APOA5 and hypertriglyceridemia: The differences in the prevalence of decreasing serum HDL-C and elevating serum TG levels according to SCG together with APOA5 −1131T>C polymorphism suggest that SCG may act as a significant risk factor of hypo-HDL-C-emia and hypertriglyceridemia susceptibility.